Luteolin Induced Hippocampal Neuronal Pyroptosis Inhibition by Regulation of miR-124-3p/TNF- α /TRAF6 Axis in Mice Affected by Breast-Cancer-Related Depression.
Qing ZhuPan MengYuanshan HanHui YangQin YangZhuo LiuYuhong WangMinghui LongPublished in: Evidence-based complementary and alternative medicine : eCAM (2022)
/TRAF6-related pathway and inhibiting neuronal cell pyroptosis and subsequent inflammation. Therefore, luteolin may be a potential drug candidate in the treatments of BCRD.
Keyphrases
- cerebral ischemia
- nlrp inflammasome
- drug induced
- oxidative stress
- diabetic rats
- high glucose
- single cell
- rheumatoid arthritis
- depressive symptoms
- cell therapy
- signaling pathway
- subarachnoid hemorrhage
- high fat diet induced
- blood brain barrier
- sleep quality
- human health
- emergency department
- stem cells
- type diabetes
- endothelial cells
- insulin resistance
- skeletal muscle
- adipose tissue
- mesenchymal stem cells